Explore the road to hierarchical diabetes management at primary care settings in China

China Diabetes Society committee meeting was held in Zunyi, Guizhou on September 30, 2016. It marked the launch of ROADMAP study (road to hierarchical diabetes management at primary care settings in China).

Mr. Liangyou Wu, leader of chronical disease center, CDC, MOH, Mr. Chuan Chen, secretary general of the Bethune Charitable Foundation, Professor Weiping Jia, chairwoman of Chinese Diabetes Society, Professor Puhong Zhang, associate director of The George Institute, China, Mr. Cong Li, general manager of TongHuaDongBao group and more than 30 experts joined the meeting and put forward the direction and significance of the study.

Under the guidance of the National Health and Family Planning Commission and delegated by the Bethune Charitable Foundation, Chinese Diabetes Society will work together with The George Institute, China to accomplish the study. Professor Weiping Jia will take the responsibility of principal investigator and The George Institute, China will take charge of project design, execution and evaluation.

The study attempts to establish the technology platform of hierarchical diagnosis and treatment of diabetes at primary care settings in China following up the Guiding Opinions on Promoting the Construction of the Hierarchical System of Diagnosis and Treatment issued by the General Office of the State Council in September 2015.Professor Zhang said, “ROADMAP will strictly verify and evaluate the four-in-one interventions. We hope it could make great contribution to China’s hierarchical diabetes management.”

Professor Jia said, “Differing from previous hospital-based clinical researches, ROADMAP study will base on the grass roots. Moreover, it will conducted in different places at the same time to guarantee the feasibility and effectiveness.”

Mr. Wu said, “The great significance of the study is obviously there for China’s chronic disease management. Zunyi meeting is a historical point for Chinese revolution and we hope today’s Zunyi meeting could also be an indicator of the success of the study.”